Although heart disease is the leading cause of death in the United States, a significant portion of people who experience ...

Cleerly aims to use its AI-driven plaque detection technology to develop a new standard of care for heart disease.

The company has generated evidence that shows its system is better than experts at assessing vessel narrowing, plaque volume ...

Cleerly has claimed an additional $106 million in funding to boost the reach of its artificial intelligence programs for ...

Welcome to Startups Weekly — your weekly recap of everything you can’t miss from the world of startups. Want it in your inbox ...

Cleerly, a leader in advanced cardiovascular imaging, announced the successful closure of its Series C extension funding round, raising a total of $106 million. This funding round was led by global ...

The investment is the second in as many weeks for Morgan Health, which co-led $80 million round in autism-focused startup, ...

Cleerly software is an AI-enabled digital care platform to support physicians to precisely identify, and define heart disease by analyzing non-invasive CCTA images. Cleerly supports precision ...

DENVER--(BUSINESS WIRE)--Cleerly, a pioneer in advanced cardiovascular imaging, is thrilled to announce that the American Medical Association (AMA) has approved a CPT Category I code for its AI ...

Cleerly has concluded a $106m Series C funding round to advance its AI-driven coronary artery disease (CAD) platform. The US-based digital healthcare company’s non-invasive AI-Quantitative ...